Faculty & Staff
Contact
Organization:
Sidney Kimmel Medical College
834 Chestnut Street
Benjamin Franklin House, Suite 320
Philadelphia, PA 19107
For Patient Inquiries
New Patients: 1-800-JEFF-NOW
Existing Patients: 215-955-8874
Executive Committee
The Medical Oncology Executive Committee actively seeks to make continual advancements in the department with a vision to build programs to enhance our reputation and recognition, develop process excellence, establish strong human resources and expertise, and to achieve financial success in all academic, research and clinical care arenas.
With these goals in mind, the specific objectives of the Medical Oncology Executive Committee include:
Academic Excellence
- Highly skilled and regarded faculty
- Timely, compassionate, and appropriate care
- Preferred regional oncology provider
- High level of internal (TJU) and external (regional) respect
- State-of-the-art clinical programs in all common malignancies
- State-of-the-art clinical programs in selected rarer malignancies
- Bench to bedside translation in selected programs
- Conduct of outstanding/desirable investigator initiated and pharmaceutical trials
- Outstanding teaching programs attracting outstanding trainees
Financial Profitability
- Efficient and Profitable practice
- Profitability rewards existing programs and grows new ones
- Established philanthropy
- Established grant base
- Profitable clinical trials operation
- New opportunities for growth and revenue generation can be seized
Personal Satisfaction
- Type A - desire to be the best
- Climate of collegiality/teamwork
- Efficient, pleasant environment which enhances productivity
- Satisfaction from seeing growth and development of new programs
Standing Members
- Andrew Chapman, DO
Vice Chairman for Clinical Operations - Allison Zibelli, MD
Director, Division of Regional Cancer Care - Joanne Filicko-O'Hara, MD
Director, Education & Training Programs - Wm. Kevin Kelly, DO
Director, Division of Solid Tumor Oncology - Ron Myers, PhD
Director, Division of Population Science - Pierluigi Porcu, MD
Director, Division of Hematologic Malignancies